THE DEAL, AT A GLANCE
From the announcementCroíValve
01What it doesCroíValve is a clinical stage medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation with…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by the financing will be usedFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedCroíValve raised $27M Series B, announced 2026-06-23From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
CroíValve · Financing Record
Explore source-linked visual explanations for CroíValve. Unsupported claims are withheld while source review continues.
Record 6557 · Recorded date: 2026-06-23
Explore company records →